Japan · Delayed Price · Currency is JPY Delta-Fly Pharma Statistics
Total Valuation
TYO:4598 has a market cap or net worth of JPY 2.25 billion. The enterprise value is 2.01 billion.
| Market Cap | 2.25B |
| Enterprise Value | 2.01B |
Important Dates
The next estimated earnings date is Friday, May 15, 2026.
| Earnings Date | May 15, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
TYO:4598 has 12.16 million shares outstanding. The number of shares has increased by 29.12% in one year.
| Current Share Class | 12.16M |
| Shares Outstanding | 12.16M |
| Shares Change (YoY) | +29.12% |
| Shares Change (QoQ) | +4.07% |
| Owned by Insiders (%) | 9.85% |
| Owned by Institutions (%) | 2.41% |
| Float | 10.38M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | n/a |
| PB Ratio | 10.92 |
| P/TBV Ratio | 10.92 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | -1.21 |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 2.41
| Current Ratio | 2.41 |
| Quick Ratio | 2.34 |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -370.98% and return on invested capital (ROIC) is -230.05%.
| Return on Equity (ROE) | -370.98% |
| Return on Assets (ROA) | -179.40% |
| Return on Invested Capital (ROIC) | -230.05% |
| Return on Capital Employed (ROCE) | -796.62% |
| Weighted Average Cost of Capital (WACC) | 0.24% |
| Revenue Per Employee | n/a |
| Profits Per Employee | -127.85M |
| Employee Count | 13 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
In the past 12 months, TYO:4598 has paid 2.00 million in taxes.
| Income Tax | 2.00M |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -67.66% in the last 52 weeks. The beta is -0.73, so TYO:4598's price volatility has been lower than the market average.
| Beta (5Y) | -0.73 |
| 52-Week Price Change | -67.66% |
| 50-Day Moving Average | 224.46 |
| 200-Day Moving Average | 482.38 |
| Relative Strength Index (RSI) | 32.24 |
| Average Volume (20 Days) | 442,760 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
| Revenue | n/a |
| Gross Profit | n/a |
| Operating Income | -1.65B |
| Pretax Income | -1.66B |
| Net Income | -1.66B |
| EBITDA | -1.65B |
| EBIT | -1.65B |
| Earnings Per Share (EPS) | -152.73 |
Balance Sheet
The company has 240.00 million in cash and n/a in debt, with a net cash position of 240.00 million or 19.74 per share.
| Cash & Cash Equivalents | 240.00M |
| Total Debt | n/a |
| Net Cash | 240.00M |
| Net Cash Per Share | 19.74 |
| Equity (Book Value) | 206.00M |
| Book Value Per Share | 17.22 |
| Working Capital | 168.00M |
Cash Flow
| Operating Cash Flow | n/a |
| Capital Expenditures | n/a |
| Depreciation & Amortization | 1.00M |
| Net Borrowing | n/a |
| Free Cash Flow | n/a |
| FCF Per Share | n/a |
Margins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
TYO:4598 does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -29.12% |
| Shareholder Yield | -29.12% |
| Earnings Yield | -73.88% |
| FCF Yield | n/a |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | n/a |